Resources Sustainable Industrial Practices Sustainable Practices in Pharma Industry

Perspective on pharma: tackling AMR through sustainable antibiotic production

Sustainable Practices in Pharma Industry

Summary

A discussion on why a sustainable approach to developing antibiotics sustainably is key to combatting antimicrobial resistance (AMR).

Perspectives and insights

  • By 2050 AMR is predicted to cause 10 million global deaths per year, more than obesity and all cancers combined.
  • China and India produce the vast majority of antibiotic APIs and finished dose antibiotics
  • A study in Hyderabad, India, found concentrations of antibiotics in treated wastewater higher than those found in the blood of patients being treated with antibiotics
  • Sustainable antibiotics can be achieved in two key ways: Making antibiotics in a sustainable way by adopting wastewater emission targets and buying antibiotics and antibiotic ingredients only from responsible sources to ensure a clean supply chain.
  • Efforts are being made to improve sustainability of supply chains, most notably through the Pharmaceutical Supply Chain Initiative (PSCI) which requires members to complete five supplier audits each year.